Browse studies, page 1317

Page 1317 of 1,318, newest first. Search them all at once, ranked by relevance, in Evidence Hub.

• Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniae Journal of Antimicrobial Chemotherapy, 1999
• A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia Antimicrobial Agents and Chemotherapy, 1997
• Levofloxacin, a second-generation fluoroquinolone Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, 1998
• In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin Antimicrobial Agents and Chemotherapy, 1992
• Levofloxacin: a therapeutic review Clinical Therapeutics, 1998
• Adsorption behavior of the antibiotic levofloxacin on microplastics in the presence of different heavy metals in an aqueous solution Chemosphere, 2020
• Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure Alimentary Pharmacology & Therapeutics, 2005
• Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract Drugs, 1998
• High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm Clinical Infectious Diseases, 2003
• Levofloxacin : a review of its use as a high-dose, short-course treatment for bacterial infection Drugs, 2008
• Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway Journal of Neuroinflammation, 2019
• Resistance to Levofloxacin and Failure of Treatment of Pneumococcal Pneumonia New England Journal of Medicine, 2002
• Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia New England Journal of Medicine, 2005
• Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials JAMA, 1998
• Randomized Controled Multicentric Trial, of Non Inferiority, Comparing Two Durations of Antibiotherapy (5 Days Versus 10 Days) in COMMUNAUTARY Acute Uncomplicated Pyelonephritis ClinicalTrials.gov · COMPLETED, 2011
• A Randomized, Observer-masked, Parallel-group, Multicenter Trial Evaluating the Ocular Penetration of 1.5% Levofloxacin Ophthalmic Solution and 0.5% Moxifloxacin Ophthalmic Solution in Subjects Undergoing Corneal Transplant Surgery ClinicalTrials.gov · TERMINATED
• A Phase 3, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy and Safety of IV Eravacycline Compared With Ertapenem in Complicated Urinary Tract Infections ClinicalTrials.gov · COMPLETED, 2018
• Assessment of the Effects and Tolerability of RD03/2016 (Levofloxacin; Ketorolac Trometamol 0.5+0.5% w/v Eye Drops Solution) for the Treatment of Bacterial Conjunctivitis in Adults: a Multicentre, Randomized, Blinded-assessor, Phase II Non Inferiority Study - MIRAKLE ClinicalTrials.gov · COMPLETED, 2023
• Comparing the Efficacy of 14-day Therapy Doxycycline With Bismuth Subsalicylate Versus Levofloxacin With Tinidazole on Rate of Eradication of Helicobacter Pylori Infected Patients on Syrian Population ClinicalTrials.gov · COMPLETED, 2020
• A Single- Centre, Randomised Study Of The Clinical And Microbiological Efficacy Of Decreasing The Dosage Of Levofloxacin 0,5% Eye Drops As Compared To Standard Eye Drop Dosage In Patients With Bacterial Conjunctivitis ClinicalTrials.gov · COMPLETED, 2006
• Efficacies of Two Bismuth Quadruple Therapies in the Second-line Treatment of H Pylori Infection - a Multi-center Randomized Controlled Trial ClinicalTrials.gov · COMPLETED, 2020
• Phase I Clinical Trial, to Evaluate the Safety and Tolerability of the Ophthalmic Solution PRO-174 Versus Sophixín Ofteno®, Elaborated by Laboratorios Sophia on the Ocular Surface of Ophthalmological and Clinically Healthy Subjects ClinicalTrials.gov · COMPLETED, 2018
• Prospective Randomized Study to Compare Clinical Outcomes in Patients With Osteomyelitis Treated With Intravenous Antibiotics Versus Intravenous Antibiotics With an Early Switch to Oral Antibiotics ClinicalTrials.gov · TERMINATED, 2018
• Efficacies of Antimicrobial Susceptibility-Guided Versus Empirical Therapy for Rescue Treatment of Helicobacter Pylori Infection-A Randomized Clinical Trial ClinicalTrials.gov · COMPLETED, 2019
• Aqueous Humour Concentrations After Topical apPlication of combinEd Levofloxacin-dexamethasone Eye dRops and of Its Single Components: a randoMized, assEssor-blinded, Parallel-group Study in Patients Undergoing Cataract Surgery - iPERME ClinicalTrials.gov · COMPLETED, 2018
• A Phase II, Multi-Center, Randomized, Parallel Controlled Study to Evaluate the Clinical Efficacy and Safety of IVIEW 1201 Compared to Ofloxacin Eye Drops in the Treatment of Acute Bacterial Conjunctivitis ClinicalTrials.gov · COMPLETED, 2024
• An Open-label, Randomized, 3-way Crossover Study to Evaluate the Bioequivalence of an Oral Suspension Formulation, an Oral Solution Formulation, and the Marketed Tablet Formulation of Levofloxacin in Healthy Subjects ClinicalTrials.gov · COMPLETED, 2002
• A Multicenter, Active-Controlled, Randomized Study to Evaluate the Safety and Efficacy of Oral Levofloxacin Versus Cefaclor in the Treatment of Acute Bacterial Exacerbation of Chronic Bronchitis in Adults ClinicalTrials.gov · COMPLETED, 1994
• Phase 4 Study of Azitromicin in the Treatment of PID ClinicalTrials.gov · COMPLETED, 2010
• Comparative Study of the Levofloxacin-Based and Clarithromycin-Based Triple Therapy in First-Line Treatment for Helicobacter Pylori Eradication and Change of Gut Flora and Drug Susceptibility Before and After Treatment ClinicalTrials.gov · COMPLETED, 2009
• Evaluation of Two Strategies of Antibiotic Treatment With Levofloxacin in Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Short Treatment-versus Treatment Guided by Markers of Inflammation ClinicalTrials.gov · COMPLETED, 2019
• Assessment of Hematological Effect of H.Pylori and H.Pylori Eradication Therapy Among a Sample of Iraqi ITP Patients ClinicalTrials.gov · COMPLETED, 2025
• A Randomized, Double-masked, Parallel Group Study of DE-108 Ophthalmic Solution in Patients Who Are Scheduled for Cataract Surgery (Levofloxacin 0.5% Ophthalmic Solution as a Comparator) - Phase III, Confirmatory Study of Perioperative Bacteria Eradication - ClinicalTrials.gov · COMPLETED, 2017
• A Randomized, Double-Blind, Comparative, Multi-Center Study of the Safety and Efficacy of TG-873870(Nemonoxacin) Versus Levofloxacin in Adult Patients With Community-Acquired Pneumonia (CAP) ClinicalTrials.gov · COMPLETED, 2012
• A Randomized, Prospective Double-Blind, Placebo-Controlled Trial of Prophylactic Oral Levofloxacin Following Chemotherapy for Lymphoma and Solid Tumors ClinicalTrials.gov · COMPLETED, 2005
• An Open-label, Multi-center, Non-comparative Sinus Puncture Study of 750 mg, Short-course Levofloxacin in the Treatment of Acute Maxillary Sinusitis ClinicalTrials.gov · COMPLETED, 2005
• TREATMENT OF ACUTE UNCOMPLICATED PYELONEPHRITIS WITH SHORT COURSE LEVOFLOXACIN A Pilot Study ClinicalTrials.gov · TERMINATED, 2005
• A Phase 3, Randomized, Multicenter, Double-Blind Study to Evaluate the Efficacy and Safety of Plazomicin Compared With Meropenem Followed by Optional Oral Therapy for the Treatment of Complicated Urinary Tract Infection (cUTI), Including Acute Pyelonephritis (AP), in Adults ClinicalTrials.gov · COMPLETED, 2016
• An Open-Label Study of Levofloxacin to Evaluate Bacteriologic Outcome in the Treatment of Children Who Are at Risk for Acute Otitis Media That is Difficult to Treat ClinicalTrials.gov · COMPLETED, 2003
• The Clinical Trial of Methylene Blue Application Combined With Photodynamic Therapy for Treatment of SARS-CoV-2 Infected Patients ClinicalTrials.gov · COMPLETED, 2020
• Personalized Treatment for Refractory H Pylori Infection ClinicalTrials.gov · COMPLETED, 2021
• A Multicenter, Double-Blind, Randomized Study To Compare The Safety And Efficacy Of Oral Levofloxacin With That Of Ciprofloxacin HCl In The Treatment Of Complicated Urinary Tract Infections In Adults ClinicalTrials.gov · COMPLETED, 1995
• Swiss PACK-CXL (Photoactivated Chromophore for Infectious Keratitis Cross-linking) Multicenter Trial for the Treatment of Infectious Keratitis ClinicalTrials.gov · COMPLETED, 2020
• Evaluation of Corneal Hysteresis and Corneal Resistance Factor After Corneal Cross-linking for Keratoconus ClinicalTrials.gov · COMPLETED, 2010
• Phase I, Single and Multi-dose, Placebo Controlled, Randomized, Dose-Escalation Study to Evaluate the Safety, Tolerability and PK Profile of MP-376 Using the PARI eFlow Nebulizer for 14 Days to CF Patients ClinicalTrials.gov · COMPLETED, 2007
• Antibiotic Treatment for 7 Days Versus 14 Days in Patients With Acute Male Urinary Tract Infection Due to Fluoroquinolones Susceptible Bacteria: a Multicentre, Non-inferiority, Double Blind, Randomized Placebo-controlled Trial ClinicalTrials.gov · COMPLETED, 2019
• A Double-blind, Randomized Controlled Pilot Study Comparing the Safety and Efficacy of Intracameral Levofloxacin and Intracameral Cefazolin in Cataract Surgery ClinicalTrials.gov · COMPLETED, 2024
• Phase I/II Randomized, Open-label Trial to Evaluate the PK, Safety, and Outcomes of Treatment Including High Dose Rifampicin +/- Levofloxacin vs Standard Treatment for Pediatric Tuberculous Meningitis (TBM) ClinicalTrials.gov · COMPLETED, 2020
• Refining Multidrug Tuberculosis Treatment with the Ultra Short All Oral Regimen ClinicalTrials.gov · COMPLETED, 2024
• A Multi-center, Randomized, Double-Blind, Parallel Comparative, Phase III Study to Evaluate the Efficacy and Safety of Intravenous Infusion of Nemonoxacin Versus Levofloxain in Treating Adult Patients With CAP ClinicalTrials.gov · COMPLETED, 2017
• A Phase IV Comparative Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment of Subjects With Acute Bacterial Sinusitis ClinicalTrials.gov · COMPLETED
• Comparative Controlled Trial of Treatment of Minor Unexpected Uterine Cavity Abnormalities Diagnosed by Office Hysteroscopy Screening in Women Indicated for IVF ClinicalTrials.gov · TERMINATED, 2009
• Bioequivalence Study of Levomerc (Levofloxacin) 500 mg Tablet With Tavanic (Levofloxacin) 500 mg Tablets ClinicalTrials.gov · COMPLETED, 2012
• Antibiotyping and Prevalence of Virulent Genotypes Among Helicobacter Pylori and Their Impact on Response to Therapy ClinicalTrials.gov · COMPLETED, 2025
• Population Pharmacokinetics of Levofloxacin in Intensive Care Patients With Severe Community-acquired Pneumonia ClinicalTrials.gov · COMPLETED, 2014
• A Study of Sodium Carboxymethylcellulose for Post Cataract Surgery Dry Eye Symptoms ClinicalTrials.gov · COMPLETED, 2013
• An Open-Label Randomized Multiple-Dose Study to Evaluate Levofloxacin Steady-State Pharmacokinetics and Safety in Subjects With Varying Degrees of Renal Function ClinicalTrials.gov · COMPLETED, 2006
• A Phase 3, Randomized, Double-blind, Double-dummy, Multicenter, Prospective Study to Assess the Efficacy and Safety of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infections ClinicalTrials.gov · COMPLETED, 2015
• A Prospective Randomized Trial of Levofloxacin-amoxicillin Triple Therapy vs. Levofloxacin-tetracycline Quadruple Therapy in Second-line Helicobacter Pylori Treatment ClinicalTrials.gov · COMPLETED, 2017
• A Randomized Control Trial Of High-Dose Isoniazid Adjuvant Therapy For Multidrug Resistant Tuberculosis ClinicalTrials.gov · COMPLETED, 2006
• An Interventional, Open Label, Non-randomized, Phase Ia Safety and Tolerability Study of Levofloxacin Ocular Implant in Subjects Undergoing Routine Cataract Surgery ClinicalTrials.gov · COMPLETED, 2021
• Evaluation of the Performance of MAF-1217 on Surgery Induced DED When Administered Pre-operatively in Patients Undergoing Cataract Surgery ClinicalTrials.gov · COMPLETED, 2019
• A Multicenter, Double-Blind Study to Compare the Safety and Efficacy of Levofloxacin to That of Ciprofloxacin in the Treatment of Chronic Prostatitis ClinicalTrials.gov · COMPLETED, 2001
• Double-Blind, Placebo-Controlled Study of Three-Month Treatment With the Combination of Ofloxacin and Roxithromycin in Recent-Onset Reactive Arthritis ClinicalTrials.gov · COMPLETED, 1998
• Case Report: Dynamic susceptibility-informed therapy for bile leak-associated intra-abdominal Stenotrophomonas maltophilia infection Frontiers in medicine, 2026
• A Case Report of Complex Co-infection with Talaromyces marneffei and Rhodococcus equi in a Patient with AIDS 2026
• Genetic characteristics and antimicrobial resistance profile of non-typeable Haemophilus influenzae from the respiratory tract in a tertiary hospital in southwest China 2026
• Revealing the disease spectrum of acute Q fever in China's Coastal Areas: A Series Study of 11 Cases from Yantai 2026
• Spondylodiscitis due to Stenotrophomonas maltophilia after endoscopic spine surgery: a case report 2026
• Heatmap-Based and Regression Analysis of Antibiotic Co-Resistance Networks Among Gram-Positive Bacterial Isolates in a Tertiary Care Hospital 2026
• Levofloxacin hemihydrate-adorned floating drug delivery system to ameliorate H. pylori infection: formulation development, optimization, and characterization Drug development and industrial pharmacy, 2026
• Emergence of serotype 23F among levofloxacin-resistant invasive Streptococcus pneumoniae in the Republic of Korea: Association with the expansion of GPSC6 Journal of infection and public health, 2026
• Comparative effectiveness of genotype-guided and empirical bismuth-containing quadruple therapy for Helicobacter pylori eradication: a retrospective study Frontiers in pharmacology, 2026
• Comparative effectiveness of levofloxacin versus third-generation cephalosporins and predictors of treatment outcomes in upper respiratory tract scleroma: a tertiary center experience Scientific reports, 2026
• Ferrocene-functionalized NH2-UiO-66/MoO3 ratiometric electrochemical sensing platform for efficient monitoring of levofloxacin Mikrochimica acta, 2026
• The impact of long-term levofloxacin on the bacterial gut microbiome of young South African children bioRxiv, 2026
• Prediction of antimicrobial resistance of Klebsiella pneumoniae through machine learning and revelation of significant role of insertion sequence elements 2026
• Disseminated tuberculosis in adolescent systemic lupus erythematosus after negative baseline screening: a case report 2026
• Evaluation of antibiotic resistance rates in S. Aureus infections by years: A 6-year retrospective study (2019-2024) in IZMIR, TURKIYE 2026
• Exploring the evolution of multidrug resistance patterns in ESKAPEE pathogens using association mining: Key to antibiotic stewardship? 2026
• Comparative Efficacies Of Current Second And Third Generation Fluoroquinolone Antibiotics On Systemic Escherichia Coli In Broiler Chickens In Qalyubia Farms 2026
• Levofloxacin-associated tendon disorders: Sex-, age-, and route-specific disproportionality analysis using FAERS and JADER. PloS one, 2026
• Synergistic Effect of Zinc Oxide Nanoparticles with Antibiotics Against Resistant Staphylococcus aureus Isolated from SSTIs: A Cross-Sectional In Vitro Study 2026
• Diagnostic Performance of Fluorescence-Based Rapid On-Site Specimen Evaluation for Helicobacter pylori Antimicrobial Susceptibility Testing Before and After Algorithm Optimization: A Two-Round Comparative Study 2026
• Lytic bacteriophages against Salmonella Typhi as a potential alternative to antibiotics 2026
• Real-World Practices of Fluoroquinolone Prophylaxis in Spontaneous Bacterial Peritonitis: A Longitudinal Study from a Tertiary Care Center in North India 2026
• Levofloxacin-based concomitant versus sequential therapy for Helicobacter pylori eradication in treatment-naïve Syrian patients: a randomized trial showing no superiority of sequential therapy Gut pathogens, 2026
• Comparative Analysis of Antimicrobial Resistance Patterns among Uropathogenic Escherichia coli and Klebsiella pneumoniae Isolates from Referral Hospitals in Chad and Cameroon 2026
• Bacterial Profile and Antimicrobial Susceptibility Patterns among Neonates with Suspected Sepsis at a Tertiary Hospital (ACSH) in Tigray, Northern Ethiopia: A Prospective Observational Study 2026
• Microbial etiology, antibiotic susceptibility profiles, and multidrug resistance of urinary tract infections at a secondary healthcare facility in Ghana medRxiv, 2026
• Effect of Cranberry Plant Extract on Gene Expression in Antibiotic-Resistant and Biofilm-Forming Staphylococcus aureus and Streptococcus agalactiae Isolated from Vaginal Infections 2026
• Fluoroquinolone-Triggered Prophage Induction in Streptococcus anginosus Reveals Lytic Cycle, CRISPR–Prophage Interplay, and the potential for Cross-Species Horizontal Gene Transfer 2026
• Staphylococcus aureus Mnh1 cation–proton antiporter promotes phagocytic uptake and intracellular survival in human monocytes 2026
• Antimicrobial Susceptibility Profiles and Associated Clinical Risk Factors of Stenotrophomonas maltophilia Isolated from Blood Cultures: A Retrospective Study 2026
• Effects of levofloxacin eye drops on ocular surface bacterial colonization and postoperative infection rate in patients undergoing blepharoplast Pakistan journal of pharmaceutical sciences, 2026
• Risk factors and antimicrobial resistance of ESBL-positive Enterobacter cloacae complex bloodstream infections: a retrospective clinical and molecular study 2026
• Identification and Antibiogram Assay of Escherichia coli Isolated from Chicken Eggs 2026
• Increased Prevalence of Multidrug-Resistant Escherichia coli as an Adverse Effect of Excessive Antibiotic Use in a Tertiary Care Hospital in Serbia Life (Basel, Switzerland), 2026
• High-level ciprofloxacin resistance in Pseudomonas aeruginosa is associated with genomic adaptation, collateral antibiotic susceptibility, and physiological trade-offs 2026
• Antimicrobial Resistance Patterns in Uropathogens Isolated from Type 2 Diabetic Patients in a Tertiary Hospital, Ghana: A Cross-Sectional Approach 2026